Montserrat

Reimbursed Care Access

Montserrat regulates controlled drugs under its Drugs (Prevention of Misuse) legislative framework (territorial law following UK-style scheduling). Routine medical use of general anaesthetics and some controlled drugs (e.g., ketamine as an anaesthetic) is permitted under medical/clinical regulation and licensing; classical psychedelic compounds (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) are treated as controlled/prohibited substances with no authorised medical programme and no broad public reimbursement—legal access is essentially limited to authorised clinical research or individual licences under the Drugs (Prevention of Misuse) regulatory provisions where such licences are granted. [https://montserratfocus.com/montserrats-police-chief-reminds-visitors-that-cannabis-is-still-illegal/|Montserrat Focus] [https://jcpc.uk/cases/judgments/jcpc-2022-0084|Judicial Committee of the Privy Council (Montserrat guidance on Drugs Act provisions)].